GLMD

Galmed Pharmaceuticals Ltd. GLMD

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode GLMD BIVI TOVX MLEC CMMB INM BDRX VRAX ELAB ISPC
6M -49.70 % -86.58 % -54.43 % -96.06 % -58.26 % -46.73 % -64.65 % -50.03 % -76.29 % -55.58 %
YTD -73.49 % -93.78 % -88.15 % -96.63 % -76.88 % -72.81 % -92.05 % -82.81 % -97.19 % -86.21 %
1Y -70.95 % -93.42 % -84.96 % -96.56 % -70.15 % -72.12 % -91.49 % -80.22 % -97.33 % -86.36 %
3Y -99.09 % -99.79 % -98.14 % -97.09 % -79.13 % -95.06 % -99.99 % -93.34 % -99.99 % -98.55 %
5Y -99.87 % -99.91 % -99.78 % -97.18 % -98.61 % -99.92 % -100.00 % -99.79 % -99.99 % -99.73 %
10Y -99.94 % -99.10 % -100.00 % -97.18 % -99.71 % -99.93 % -100.00 % -99.79 % -99.99 % -99.73 %
Depuis le début -99.97 % -99.64 % -100.00 % -97.18 % -99.71 % -99.97 % -100.00 % -99.79 % -99.99 % -99.73 %

Dividende